Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease—review of the literature
- 529 Downloads
Stricturing Crohn’s disease is accompanied by a high-risk for bowel resection and subsequent short bowel syndrome. Strictureplasty (SP) and endoscopic balloon dilatation (EBD) have been developed to prevent, or at least delay, the requirement for resection. The goal of this study was to compare the outcome of these two procedures with regard to complications and disease recurrence.
We conducted a MEDLINE literature search to give a current overview about the safety and efficacy of EBD and SP.
The initial search yielded 744 articles. Case reports, reviews and meta-analyses were excluded. Finally, 63 articles (SP, 40 articles; EBD, 23 articles) were used for the review. None of the studies compared the two methods directly. A total of 2,532 patients (SP, n = 1,958; EBD, n = 574) were included. The incidence of perioperative complications after SP was 11% and the incidence of major complications was 5%. The median surgical recurrence rate was 24% after a median follow-up of 46 months. The median technical success for EBD was 90%. Major complications occurred in 3% of the cases. According to an intention-to-treat protocol, the median surgical recurrence rate was 27.6%. Per-protocol analysis revealed a median surgical recurrence rate of 21.4% after a median follow-up of 21 months.
Due to the lack of comparable data, there is currently no reliable information on whether one treatment option is superior to the other. Regarding the limited applicability of EBD in strictures of the small bowel, only a controlled trial would provide evidence as a basis for clinical decision making in CD strictures that are potentially treatable by EBD and SP.
KeywordsCrohn’s disease Crohn’s stricture Strictureplasty Endoscopic balloon dilatation
- 3.Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease. Gut 39:690–697CrossRefPubMedGoogle Scholar
- 4.Jess T, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ (2006) Survival and cause specific mortality in patients with inflammatory bowel disease: a long-term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 55:1248–1254CrossRefPubMedGoogle Scholar
- 6.Stange EF, Schreiber S, Fölsch UR, von Herbay A, Schölmerich J, Hoffmann J, Zeitz M, Fleig WE, Buhr HJ, Kroesen AJ, Moser G, Matthes H, Adler G, Reinshagen M, Stein J, German Society for Digestive and Metabolic Diseases (2003) Diagnostics and treatment of Crohn’s disease—results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases. Z Gastroenterol 41:19–20CrossRefPubMedGoogle Scholar
- 9.Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M (2008) Clinical practice guideline on diagnosis and treatment of Crohn’s disease. Z Gastroenterol 46:1094–1146CrossRefPubMedGoogle Scholar
- 23.Travis SP, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, D’Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ, European Crohn’s and Colitis Organisation (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut 55(Suppl 1):i16–i35CrossRefPubMedGoogle Scholar
- 40.Silverman RE, McLeod RS, Cohen Z (1989) Strictureplasty in Crohn’s disease. Can Assoc Clin Surg 32:19–22Google Scholar
- 65.Michelassi F, Taschieri A, Tonelli F, Sasaki I, Poggioli G, Fazio V, Upadhyay G, Hurst R, Sampietro GM, Fazi M, Funayama Y, Pierangeli F (2007) An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum 50:277–284CrossRefPubMedGoogle Scholar
- 85.Raedler A, Peters I, Schreiber S (1997) Treatment with azathioprine and budesonide prevents reoccurrence of ileocolonic stenoses after endoscopic dilatation in Crohn’s disease (Abstract). Gastroenterology 112:A1067Google Scholar